Latest Trials
| EudraCT Number: 2018-002611-99 | Sponsor Protocol Number: 20090 | Start Date: | |||||||||||
| Sponsor Name: Bayer AG | |||||||||||||
| Full Title: Open-label, randomized, two–arm, controlled study to assess the efficacy, safety, and tolerability of intravitreal (IVT) aflibercept compared to laser photocoagulation in patients with retinopathy ... | |||||||||||||
| Medical condition: Retinopathy of prematurity | |||||||||||||
|
|||||||||||||
| Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: CZ (Completed) SE (Completed) NL (Completed) PT (Completed) GB (GB - no longer in EU/EEA) BE (Completed) DE (Completed) SK (Completed) AT (Completed) BG (Completed) PL (Completed) ES (Completed) HU (Completed) LT (Completed) EE (Completed) LV (Completed) GR (Completed) IT (Completed) RO (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||